Institutional investors purchased a net $80.6 thousand shares of CYCC during the quarter ended September 2016, and now own 31.97% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TANG CAPITAL MANAGEMENT LLC Bought 200.0 Thousand shares of Cyclacel Pharmaceuticals ...
THE VANGUARD GROUP, INC. Bought 41.3 Thousand shares of Cyclacel Pharmaceuticals ...